Padagis is dedicated to improving the well-being of patients and consumers by providing high quality, affordable, specialized healthcare products. The company is a leading provider of extended topical and other specialty pharmaceuticals.

Azurity specializes in providing innovative, high-quality medicines that serve overlooked patients. It supplies a large number of products to treat a wide range of medical conditions. These include cardiovascular, central nervous system, endocrine, gastro-intestinal, anti-infective and oncology medicines. Many of the products are dose-form innovation of established medicines for patients who have unmet needs.* Created the strategic roadmap for pipeline building at speed and scale utilizing internal development, and external partnerships. Roadmap included capacity, and capability building to deliver a development engine assuring several new launches every year.* Oversaw introduction of new ideas into prototyping across therapeutic areas and dosage forms, life cycle management process, new brand launches, authorized generic responses to competition, due-diligence, business development, and alliance management.

A specialty generic business serving the needs of hospitals, community clinics, specialty, and retail pharmacies by delivering a portfolio of sterile products. In 2022 the difficult to develop and tough to make pipeline was licensed or acquired by large generic/specialty companies. Several products have since been approved and launched including a first to market peptide based complex injectable combination product that remains the sole generic on the market.

Global, publicly-traded (NYSE: RDY) pharmaceutical company with businesses spanning generic and over-the-counter drugs, specialty/branded drugs, active pharmaceutical ingredients, biologics, drug discovery, and contract development & manufacturing services.* Leading the charge for building a sustainable and growing complex generics based business through strategic portfolio management * Collaborating with research and manufacturing partners to expand capability footprint* Mentoring r&d teams for effective management of project to filing and launch* Building organizational talent pool to aid in the growth journey* Evolving organizational strategic planning to aid in execution excellence, near term growth initiatives, and long term business building

* Constructed the blueprint for a specialty injectables generics business encompassing market research, portfolio building, and resource planning * Hired and integrated key team members* Launched the business leading to one of the fastest growing segments within North America

* Integration of a newly acquired product line, manufacturing site, quality, and information systems * Launch planning for 40+ SKU's demonstrating successful transition and integration

* Led in-licensing, and co-development deals for North America Generics* Ideated, and led an acquisition and licensing deal for antibiotics assets including product filings, brands, and manufacturing infrastructure* Strategy building for a sustainably growing generics business

* Ideating and planning growth strategies for pharma services and active ingredients business. This business provides contract research and manufacturing services as a CDMO to emerging and major pharma* Relationship management for key accounts* Sales and marketing territories over the years included North America, Japan, Korea, and Australia* Strategic initiatives including M&A

- Customization and implementation of ERP applications